- Interline Therapeutics, a San Francisco, CA-based drug discovery company, raised $92M in funding
- The round was led by Foresite Capital and ARCH Venture Partners
- The company also intends to use the funds to expand the research platform and advance six preclinical therapeutic programs
- Interline Therapeutics is a Foresite Labs incubated company that focuses on systematically elucidating protein communities to define molecular mechanisms of disease
- The company also uses genomics, proteomics, structural biology and computational chemistry to systematically map and modulate protein communities
- The company will continue to collaborate with Foresite Labs in the fields of data science and genomics
